Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

letter

. 2021 Feb 15;143(13):1338–1340. doi: 10.1161/CIRCULATIONAHA.120.053311

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 American Heart Association, Inc.

This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

PMC Copyright notice

Figure. — The frequency of elevated biomarkers reflecting myocardial injury, coagulation, and inflammation in COVID-19 and associations with in-hospital outcomes. A, Venn diagram illustrating overlap of elevated biomarkers at the time of initial hospital presentation in patients with COVID-19 and ≥1 elevated biomarker (n=2699). One hundred ninety-six patients had no elevated biomarkers. The proportion of patients with in-hospital mortality (B) and critical illness (C) are shown stratified by the number of elevated biomarkers measured at hospital presentation with COVID-19. Odds ratios (versus 0 biomarkers elevated) shown in B and C are adjusted for age, sex, race, body mass index, tobacco use, hypertension, hyperlipidemia, diabetes, chronic kidney disease, prior myocardial infarction, prior heart failure, atrial fibrillation, temperature at presentation, pulse oximetry at presentation, and outpatient prescriptions for antiplatelets, statin, and β-blockers. aOR indicates adjusted odds ratio; and CRP, C-reactive protein.